Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GlaxoSmithKline PLC

www.gsk.com

Latest From GlaxoSmithKline PLC

Wellness Industry News: GMP Complaint Against Confidence USA, Crown Labs Expands Again, More

FDA seeks injunction against Confidence USA; Crown Labs expands again; CHPA, PCPC say Environmental Working Group "irresponsibly misrepresents” evidence on sunscreen safety; Kratom Information & Resource Center says 92% of news about kratom published since February was ‘unfair and unbalanced’; more news.

Dietary Supplements Commercial

GSK Revamps Sales Reps Incentives To Be Competitive In Cancer

Seven years after a major shift in how the company compensated its sales force, the UK major has done a U-turn and is adapting pay packages for some specialty care reps.

Business Strategies Commercial

AZ, Takeda, Novartis Praised For Medicines Access Work But More Is Needed

The 20 major companies in the Access to Medicines Index have made progress in areas like inclusive business models, R&D prioritization and equitable pricing, but not enough is being done to develop new medicines for less profitable diseases or to support flexibilities such as compulsory licensing, says a new report from the Access to Medicine Foundation.

International Pricing Strategies

Cipla Claims Pricing Advantage For Albuterol In US

Cipla, which expects to enter the US albuterol inhalation market later this year, believes that it has the cost competitiveness to price “significantly lower” than competition and take a “fair share” of a market that recently saw the arrival of authorized generics.

Commercial Strategy
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register